After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Yahoo Finance discussed the stock recently as it posted Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, STOK falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $13.50 and fluctuated between $13.61 as its day high and $12.43 as its day low. The current market capitalization of Stoke Therapeutics Inc is $700.11M. A total of 0.53 million shares were traded on the day, compared to an average of 1.06M shares.
In the most recent transaction, Nash Huw M. sold 61,329 shares of STOK for 13.23 per share on Apr 01 ’24. After the transaction, the COO & CBO now owns 0 company shares. In a previous transaction on Apr 01 ’24, Ticho Barry sold 9,426 shares at 13.23 per share. STOK shares that CHIEF MEDICAL OFFICER owns now total 2,485.
Among the insiders who sold shares, Allan Jonathan disposed of 5,126 shares on Mar 28 ’24 at a per-share price of $13.20. This resulted in the GENERAL COUNSEL & CORP SEC holding 2,598 shares of STOK after the transaction. In another insider transaction, Kaye Edward M. MD sold 11,150 shares at $6.10 per share on Mar 19 ’24. Company shares held by the CEO now total 69,350.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, STOK has a high of $16.40 and a low of $3.35.
As of this writing, STOK has an earnings estimate of -$0.61 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.54 per share and a lower estimate of -$0.7. The company reported an EPS of -$0.55 in the last quarter, which was 12.70% higher than expectations of -$0.63.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. STOK’s latest balance sheet shows that the firm has $219.81M in Cash & Short Term Investments as of fiscal 2021. There were $1.51M in debt and $17.14M in liabilities at the time. Its Book Value Per Share was $3.47, while its Total Shareholder’s Equity was $217.78M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for STOK is Buy with a score of 4.67.
